Data Pulse: A Five-Time Increase in Use of Medisafe for Obesity Meds

A $260.6B Challenge: How Patients Manage Obesity Meds

Weight Management affects 650M people worldwide. Four million people die each year as a result of obesity, according to the World Health Organization [1], making it a serious global problem. Annual obesity-related medical care costs in the United States, were estimated to be $260.6B.
In the last 5 years, the popularity of medications that Medisafe users took for obesity has doubled. That jump was propelled mostly by Semaglutide medications: Wegovy and Ozempic. These meds had not substituted for types of anti-obesity meds – rather they added new patients to the population of users taking meds for weight control.

Click here to see what they are saying about it: Weight Management_Data_Pulse Report

You may also like

Medisafe Announces Launch of GOMEKLI™ Digital Companion to Support Patients with NF1-PN Taking GOMEKLI

BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration 

..Read More

Medisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards Program

LOS ANGELES, Calif., – May 8, 2025 – MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, 

..Read More

Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction

BOSTON, MA / ACCESS Newswire / April 22, 2025 / Medisafe today launched VIA (Voice Intelligent Agent) – a breakthrough 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.